Navigation Links
Weight Gaining And Losing May Increase Men's Risk For Gallstones

According to a report in the November 27 issue of Archives of Internal Medicine, a JAMA/Archives journal, weight cycling may increase men's risk for gallstones later in// life. When a solid mass of cholesterol, bile and calcium salts gets accumulated in the gall bladder, it results in the Gallstone disease.

Around 25,000 men were targeted for the study and it was found that the associations remained when researchers considered each participant's body mass index (BMI), further suggesting that it is the weight cycling, rather than being overweight or obese alone, that increases risk.

Weight cycling occurs when one tries to lose weight and then regain the weight. To assess whether weight cycling influenced the risk of developing gallstones, Dr. Chung-Jyi Tsai, University of Kentucky College of Medicine Division of Digestive Diseases and Nutrition associate professor, and colleagues analyzed data from nearly 25,000 men who were part of the Health Professionals Follow-up Study.

The Study provided information about weight fluctuations in men between 1988 and 1992 by sending questionnaires every two years from 1992 to 2002 for monitoring whether they had developed gallstone disease. It was found that gallstones were more likely in men who experienced weight cycling than in those who maintained their weight. The risk of developing gallstones by 76 percent were seen in those who were classified as severe 'cyclers' lost and regained 20 pounds or more compared to weight maintainers.
SRI
'"/>




Page: 1

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Weight-Loss Drinks Can Make You Gassy
3. Smoking Linked To Low Infant Birth Weight
4. Weight gain following smoking cessation not linked to Leptin
5. Helping Kids Attain a Healthy Weight
6. Weight-loss Products Dangerous
7. Weight and Blood Pressure
8. Low Birth Weight infants could have Problems in the Future
9. Excess Weight Can Affect Individuals as They Age
10. Low-Fat, High-Carb Diet Equally Effective In Weight Loss
11. Weight Gain Found To Increase The Risk Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient system, ... potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... 24, 2017 , ... The Santana Telehealth Project was honored with the 2017 ... American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I am ... the lives of the poor and underserved in other parts of the world,” said ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: